| Serial Number | 98421632 |
| Word Mark | NOURA |
| Filing Date | Monday, February 26, 2024 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, January 21, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the word element NOURA in light blue and positioned to the right of a schematic logo having two teal circles between a light blue semi circle. |
| Indication of Colors claimed | The color(s) light blue and teal is/are claimed as a feature of the mark. |
| Goods and Services | Retail pharmacy services; pharmacy services, namely, retail pharmacy including mail order pharmacy services; nutritional supplements and consulting; Pharmacy and medical consultant |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, July 7, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Specialty Medical Drugstore, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Philadelphia, PA 19103 |
| Event Date | Event Description |
| Monday, February 26, 2024 | NEW APPLICATION ENTERED |
| Sunday, July 7, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, July 7, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 13, 2024 | ASSIGNED TO EXAMINER |
| Saturday, September 28, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 21, 2025 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, January 21, 2025 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Saturday, September 28, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, September 28, 2024 | NON-FINAL ACTION WRITTEN |